Stay updated on Filgotinib Effects on Semen in Adult Males Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Effects on Semen in Adult Males Clinical Trial page.

Latest updates to the Filgotinib Effects on Semen in Adult Males Clinical Trial page
- Check3 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing v3.5.4, indicating a minor update to the page's content or formatting.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedLakefront Biotherapeutics NV is now listed as the sponsor for the study, replacing Galapagos NV. This reflects a shift in oversight and governance of the trial.SummaryDifference0.2%

- Check25 days agoChange DetectedThe page revision label was updated to v3.5.4, replacing the previous v3.5.3. This change represents a minor template/version update rather than content changes to the study details.SummaryDifference0.0%

- Check32 days agoChange DetectedThe update appears to be a visual/layout refresh of the Study Details page, reorganizing sections and navigation without changing the underlying study information.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page shows an updated revision tag, changing from v3.5.2 to v3.5.3, which indicates a software version update for the study page rather than a modification to the study details themselves.SummaryDifference0.1%

- Check46 days agoChange DetectedA location entry for Latvia was updated to remove the diacritic from the name (“Ādaži” → “Adazi”) while keeping the same location code (LV2164).SummaryDifference0.1%

Stay in the know with updates to Filgotinib Effects on Semen in Adult Males Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Effects on Semen in Adult Males Clinical Trial page.